Trial intelligence / Profile preview

AV Junction Ablation vs Optimal Medical Treatment in CRT Patients with AF

NCT05776797Recruiting

Sponsor
University Hospital Ostrava
Start
Apr 2023
Primary completion
Dec 2028
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by University Hospital Ostrava. Primary endpoints: Heart failure events at 3 years, 36-Item Quality of Life at 3 years and 3 more. Started Apr 2023; status: recruiting.

Beyond the preview

Go deeper on NCT05776797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05776797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call